AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29578604 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of CRC screening guidelines
Number of subjects: 504
Study 29578604 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-provider ethnicity concordance and provider's recommendation of screening
Number of subjects: 504
Study 29578604 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior CRC screening
Number of subjects: 504
Study 29578604 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived severity and susceptibility of CRC
Number of subjects: 504
Study 29578604 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of guidelines
Number of subjects: 504
Study 26551446 — intervention group
Group type: EXPERIMENTAL
Intervention: H5N1(2) - H5N1 group (2-dose priming with A/Indonesia/05/2005-H5N1-AS03B followed by booster with A/turkey/Turkey/1/2005-H5N1-AS03B)
Number of subjects: 0
Study 26551446 — intervention group
Group type: COMPARATOR
Intervention: HAV-H5N1 group (single dose of A/turkey/Turkey/1/2005-H5N1-AS03B in unprimed subjects)
Number of subjects: 0
Study 26551446 — intervention group
Group type: EXPERIMENTAL
Intervention: H5N1(2) - H5N1 group
Number of subjects: 0
Study 24791022 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap vaccination during intervention period
Number of subjects: 1530
Study 24791022 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1530
Study 22787172 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy milk
Number of subjects: 25
Study 22787172 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 25
Study 19952063 — intervention group
Group type: EXPERIMENTAL
Intervention: NTHi oral immunotherapeutic (HI‐164OV)
Number of subjects: 38
Study 17363355 — intervention group
Group type: EXPERIMENTAL
Intervention: Online haemodiafiltration
Number of subjects: 76
Study 17363355 — intervention group
Group type: COMPARATOR
Intervention: High-flux haemodialysis
Number of subjects: 76
Study 17363355 — intervention group
Group type: EXPERIMENTAL
Intervention: Both high-flux haemodialysis and online haemodiafiltration
Number of subjects: 76
Study 17363355 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (online haemodiafiltration and high-flux haemodialysis)
Number of subjects: 76
Study 15353020 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphdiaral (Pascoe, Giessen, Germany)
Number of subjects: 32
Study 15353020 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic tonsillitis nosode at a C3 potency (Spagyra, Grödig, Austria)
Number of subjects: 32
Study 11607900 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling catheter
Number of subjects: 99
Study 11607900 — intervention group
Group type: COMPARATOR
Intervention: Intermittent catheterization
Number of subjects: 99
Study 9535583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 x 400 m interval running workouts with recovery durations of 180 s
Number of subjects: 12
Study 9535583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 x 400 m interval running workouts with recovery durations of 120 s
Number of subjects: 12
Study 9535583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 x 400 m interval running workouts with recovery durations of 60 s
Number of subjects: 12
Study 9535583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 x 400 m interval running workouts (averaged across conditions)
Number of subjects: 12
Study 8009573 — intervention group
Group type: EXPERIMENTAL
Intervention: IR verapamil, 80 mg t.i.d. (Phase B)
Number of subjects: 12
Study 8009573 — intervention group
Group type: EXPERIMENTAL
Intervention: SR verapamil, 240 mg q.d. (Phase C)
Number of subjects: 12
Study 8009573 — intervention group
Group type: COMPARATOR
Intervention: IR propranolol, 160 mg (Phase A)
Number of subjects: 12
Study 8009573 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined verapamil groups (Phase B and C)
Number of subjects: 12
Study 2605788 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (4 mg bolus and 6 mg/h)
Number of subjects: 6
Study 2605788 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 6
Study 15756556 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA creme applied before upper lid blepharoplasty
Number of subjects: 14
Study 15756556 — intervention group
Group type: COMPARATOR
Intervention: Non-treated side (Control)
Number of subjects: 14
Study 31680496 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 60
Study 31680496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 60
Study 31680496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (group K)
Number of subjects: 60
Study 31430032 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced stress outcomes
Number of subjects: 77
Study 31430032 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive stress outcomes
Number of subjects: 77
Study 31430032 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative stress outcomes
Number of subjects: 77
Study 31430032 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 77
Study 27676631 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (up to 20 treatments within 6 months)
Number of subjects: 209
Study 27676631 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 209
Study 27089730 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocarnit
Number of subjects: 0
Study 27089730 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22926212 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 724
Study 22926212 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and copper supplementation
Number of subjects: 724
Study 21350422 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromidin (ipidacrinum) 80 mg/day for 3 months
Number of subjects: 40
Study 21350422 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no treatment)
Number of subjects: 40
Study 21350422 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromidin (ipidacrinum)
Number of subjects: 40
Study 19035467 — intervention group
Group type: EXPERIMENTAL
Intervention: Exact unconditional CI estimators
Number of subjects: 0
Study 19035467 — intervention group
Group type: EXPERIMENTAL
Intervention: Approximate unconditional CI estimators
Number of subjects: 0
Study 19035467 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditional two-sided-test-based CI estimators
Number of subjects: 0
Study 19035467 — intervention group
Group type: COMPARATOR
Intervention: Asymptotic CIs
Number of subjects: 0
Study 16886930 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprathreshold single and repetitive (2 Hz) electrical stimulation of muscle and skin in cephalic (temporal and trapezius) and extracephalic (anterior tibial) regions
Number of subjects: 0
Study 16886930 — intervention group
Group type: COMPARATOR
Intervention: Suprathreshold single and repetitive (2 Hz) electrical stimulation
Number of subjects: 0
Study 16886930 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal summation of muscular and cutaneous pain
Number of subjects: 0
Study 15623461 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (15% of energy from fat)
Number of subjects: 122
Study 15623461 — intervention group
Group type: EXPERIMENTAL
Intervention: High-FV diet (9 servings/d)
Number of subjects: 122
Study 15623461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low-fat/high-FV diet
Number of subjects: 122
Study 15623461 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention (control)
Number of subjects: 122
Study 11733884 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training and a conventional exercise program
Number of subjects: 60
Study 11733884 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program only (Control)
Number of subjects: 60
Study 9161368 — intervention group
Group type: COMPARATOR
Intervention: Without stabilization of the contralateral leg
Number of subjects: 75
Study 9161368 — intervention group
Group type: COMPARATOR
Intervention: With a bar in front of the ankle joint of the contralateral leg
Number of subjects: 75
Study 9161368 — intervention group
Group type: COMPARATOR
Intervention: With the contralateral leg strapped just above the level of the malleoli and the muscles of that leg induced reciprocally to perform isometric contractions with respect to the testing leg
Number of subjects: 75
Study 7509894 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg once daily)
Number of subjects: 14
Study 7509894 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily)
Number of subjects: 14
Study 7509894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2889828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed partial denture supported by blade-vent implant
Number of subjects: 272
Study 2889828 — intervention group
Group type: COMPARATOR
Intervention: Removable partial denture
Number of subjects: 272
Study 31279221 — intervention group
Group type: EXPERIMENTAL
Intervention: unguided ICBT‐P
Number of subjects: 94
Study 31279221 — intervention group
Group type: COMPARATOR
Intervention: unguided ICBT‐S
Number of subjects: 94
Study 31279221 — intervention group
Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 94
Study 28829001 — intervention group
Group type: COMPARATOR
Intervention: Single dose of 34 mg of ferrous sulfate (group A)
Number of subjects: 172
Study 28829001 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose of 34 mg of ferrous sulfate (group B)
Number of subjects: 172
Study 25733343 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management (DSM) intervention delivered by trained nurses
Number of subjects: 85
Study 25733343 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 85
Study 23838939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (6 x 9 ufc b.i.d) (n = 29)
Number of subjects: 66
Study 23838939 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 66
Study 21563507 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing Injection
Number of subjects: 80
Study 21563507 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine therapy)
Number of subjects: 80
Study 19404670 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction (MVC)
Number of subjects: 13
Study 19404670 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal contraction at 10% to 90% of MVC
Number of subjects: 13
Study 16472935 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy (PMRT)
Number of subjects: 1010
Study 12614996 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of ethyl-eicosapentaenoic acid
Number of subjects: 72
Study 12614996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 12614996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmoking women
Number of subjects: 72
Study 10839906 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol (20 mg orally 2 hours before anesthesia)
Number of subjects: 28
Study 10839906 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 28
Study 9165607 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (Minirin, DDAVP) administered with food or 90 minutes after a meal
Number of subjects: 16
Study 9165607 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (Minirin, DDAVP)
Number of subjects: 16
Study 8409152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular cefoperazone, 1 gm every 12 hours, for 10 days
Number of subjects: 104
Study 8409152 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular ceftriaxone, 1 gm every 24 hours, for 10 days
Number of subjects: 104
Study 8409152 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 104
Study 3512778 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylpentynol, 200 mg/day
Number of subjects: 6
Study 3512778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 29529161 — intervention group
Group type: COMPARATOR
Intervention: Fructose control beverage (glucose and fructose)
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Large servings of apple (410 g)
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Large servings of apple juice (340 mL)
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole apple
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Satiety scores
Number of subjects: 73
Study 29529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic response
Number of subjects: 73
Study 26956652 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation Exercise Intervention (EX)
Number of subjects: 29
Study 26956652 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 29
Study 25185430 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol administration
Number of subjects: 12
Study 25185430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22284333 — intervention group
Group type: EXPERIMENTAL
Intervention: CATMN system
Number of subjects: 26
Study 22284333 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopic technique
Number of subjects: 26
Study 20623003 — intervention group
Group type: EXPERIMENTAL
Intervention: Native banana starch (NBS)
Number of subjects: 0
Study 20623003 — intervention group
Group type: COMPARATOR
Intervention: Soy milk (control)
Number of subjects: 0
Study 18615388 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 % CHO beverage (15 mL . kg (‐1) . hr (‐1))
Number of subjects: 16
Study 18615388 — intervention group
Group type: COMPARATOR
Intervention: Water (H2O)
Number of subjects: 16
Study 16093979 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 10219
Study 16093979 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10219
Study 12439601 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour intravenous infusions of methotrexate (MTX)
Number of subjects: 20
Study 11986564 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine with low-level exercise (adenosine-Ex)
Number of subjects: 41
Study 11986564 — intervention group
Group type: COMPARATOR
Intervention: Adenosine alone
Number of subjects: 41
Study 9522108 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 245
Study 9522108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 8012639 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily
Number of subjects: 55
Study 8012639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2658040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (ATF)
Number of subjects: 68
Study 2658040 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 30782915 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP clinic care including self-monitoring instructions, BP monitor, sleep apnoea screening, dietary counselling, review of BP monitoring records, and medication adjustment.
Number of subjects: 0
Study 30782915 — intervention group
Group type: COMPARATOR
Intervention: Usual care with neurologist consultation and recommendations for secondary prevention sent to primary care providers.
Number of subjects: 0
Study 30782915 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP clinic care
Number of subjects: 0
Study 30782915 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 29270490 — intervention group
Group type: EXPERIMENTAL
Intervention: QPI‐1002 0.5 mg/kg
Number of subjects: 16
Study 29270490 — intervention group
Group type: EXPERIMENTAL
Intervention: QPI‐1002 1.5 mg/kg
Number of subjects: 16
Study 29270490 — intervention group
Group type: EXPERIMENTAL
Intervention: QPI‐1002 5.0 mg/kg
Number of subjects: 16
Study 29270490 — intervention group
Group type: EXPERIMENTAL
Intervention: QPI‐1002 10.0 mg/kg
Number of subjects: 16
Study 29270490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29270490 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined QPI‐1002 cohorts
Number of subjects: 16
Study 29270490 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 16
Study 25640831 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Books program
Number of subjects: 508
Study 25640831 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Letters program
Number of subjects: 508
Study 25640831 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 508
Study 23650501 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 hours of visual speed of processing training (on-site or at-home)
Number of subjects: 681
Study 23650501 — intervention group
Group type: COMPARATOR
Intervention: Attention control group using computerized crossword puzzles for 10 hours
Number of subjects: 681
Study 21402549 — intervention group
Group type: EXPERIMENTAL
Intervention: rAd5 HIV-1 gag vaccine
Number of subjects: 110
Study 21402549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 18959773 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir and adjuvant dexamethasone
Number of subjects: 372
Study 18959773 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir and placebo
Number of subjects: 372
Study 16424444 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol/fluticasone propionate 50/500 microg twice daily
Number of subjects: 140
Study 16424444 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study 12616578 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) with exposure-based treatment
Number of subjects: 113
Study 12616578 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) with nonexposure-based treatment
Number of subjects: 113
Study 12616578 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) with both exposure and nonexposure-based treatments
Number of subjects: 113
Study 11127455 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal progesterone gel (90 mg on alternate days) with estradiol (1 mg/day for three weeks then 2 mg/day for one week)
Number of subjects: 18
Study 11127455 — intervention group
Group type: COMPARATOR
Intervention: Estradiol/MPA therapy (10 mg/day placebo for MPA)
Number of subjects: 18
Study 9187989 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with a pulse pressure of 10 to 20 mmHg and a frequency of 60 to 80 beats/min
Number of subjects: 80
Study 9187989 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile perfusion
Number of subjects: 80
Study 8262689 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine, 0.2 mg/kg-1
Number of subjects: 12
Study 8262689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight patients (BMI category 1)
Number of subjects: 11239
Study 31478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI category 2)
Number of subjects: 11239
Study 31478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI category 3)
Number of subjects: 11239
Study 29464745 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐regulatory efficacy improvement program led by school nurses
Number of subjects: 79
Study 29464745 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 79
Study 27569274 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab with eribulin
Number of subjects: 141
Study 27569274 — intervention group
Group type: COMPARATOR
Intervention: Eribulin alone
Number of subjects: 141
Study 24607675 — intervention group
Group type: EXPERIMENTAL
Intervention: MTO housing voucher intervention
Number of subjects: 2829
Study 24607675 — intervention group
Group type: COMPARATOR
Intervention: Control group (no voucher)
Number of subjects: 2829
Study 22589290 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable iris-fixated phakic intraocular lens (PIOL) implantation
Number of subjects: 46
Study 22589290 — intervention group
Group type: COMPARATOR
Intervention: Femtosecond laser-assisted LASIK
Number of subjects: 46
Study 20216095 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed 100% whey protein formula (PHF‐W)
Number of subjects: 12
Study 20216095 — intervention group
Group type: COMPARATOR
Intervention: Intact protein cow's milk formula (CMF)
Number of subjects: 12
Study 18625896 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) 0.5 microg x kg(‐1) x min(‐1) during rewarming period
Number of subjects: 100
Study 18625896 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose 5% in water)
Number of subjects: 100
Study 18625896 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 100
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E gp120 HIV vaccine
Number of subjects: 1209
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily tenofovir HIV prophylaxis
Number of subjects: 1209
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: Community outreach intervention
Number of subjects: 1209
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational campaigns
Number of subjects: 1209
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory cohort
Number of subjects: 1209
Study 16107437 — intervention group
Group type: EXPERIMENTAL
Intervention: Seroconverter cohort
Number of subjects: 1209
Study 12122623 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine HCl aerosol (4 mg/kg of 10% lidocaine HCl applied eight times daily)
Number of subjects: 60
Study 12122623 — intervention group
Group type: COMPARATOR
Intervention: NaCl (2 ml of 0.9% NaCl applied eight times daily)
Number of subjects: 60